Viewing Study NCT04659434


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-27 @ 11:35 PM
Study NCT ID: NCT04659434
Status: UNKNOWN
Last Update Posted: 2020-12-09
First Post: 2020-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Plus R-GemOx as Second-line Salvage Therapy in Patients With R/R DLBCL
Sponsor: Qian Wenbin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module